Skip to content

Clinical trials

Phase 2/3 Neoplasm Metastasis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2/3 Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20121
20141
20151
20211
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
BioNTech SE1
Clovis Oncology, Inc.1
Eikon Therapeutics1
Exelixis1
Federation Francophone de Cancerologie Digestive1
Novartis Pharmaceuticals1
Oncoscience AG1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis10
Head and Neck Neoplasms2
Neoplasms2
Pancreatic Neoplasms2
Recurrence2
Adenoma, Islet Cell1
Anorexia1
Breast Neoplasms1
Cachexia1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.